Crossmark

CRISPR-Cas9 technology: a breakthrough in cancer gene therapy

Crossref DOI link: https://doi.org/10.1186/s43042-025-00833-1

Published Online: 2026-01-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jameel, Zahraa Isam https://orcid.org/0000-0002-1010-3957
License Information

Text and Data Mining valid from 2026-01-12

Version of Record valid from 2026-01-12
More Information

Article History

Received: 12 August 2025

Accepted: 25 December 2025

First Online: 12 January 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests of this manuscript.